These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7502864)

  • 21. [Mechanisms for the therapeutic effect of herpes polyvaccines in chronic ophthalmic herpes and genital herpes].
    Barinskiĭ IF; Karpovich LG; Gubanova EI; Belkina IV; Semenova TB; Lazarenko AA; Davydova AA; Samoĭlenko II; Kasparov AA
    Vopr Virusol; 2000; 45(1):30-3. PubMed ID: 10695041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccines for herpes simplex virus infections.
    Koelle DM
    Curr Opin Investig Drugs; 2006 Feb; 7(2):136-41. PubMed ID: 16499283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Herpes Simplex Virus Keratitis in the Pediatric Population.
    Vadoothker S; Andrews L; Jeng BH; Levin MR
    Pediatr Infect Dis J; 2018 Sep; 37(9):949-951. PubMed ID: 29794647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Herpetic pathology and current methods of treating herpetic lesions].
    Zhdanov VM; Barinskiĭ IF; Galegov GA; Ershov FI
    Sov Med; 1983; (10):65-9. PubMed ID: 6362030
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral acyclovir (Zovirax) in the treatment of recurrent herpetic gingivostomatitis and recurrent herpes labialis.
    Quong TL
    Hawaii Dent J; 1989 Oct; 20(10):10, 12, 14 passim. PubMed ID: 2630545
    [No Abstract]   [Full Text] [Related]  

  • 26. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis.
    Remeijer L; Maertzdorf J; Buitenwerf J; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):358-63. PubMed ID: 11818377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy with inactivated polyvalent herpes vaccines.
    Dundarov S; Andonov P; Bakalov B; Nechev K; Tomov C
    Dev Biol Stand; 1982; 52():351-8. PubMed ID: 6299844
    [No Abstract]   [Full Text] [Related]  

  • 28. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine].
    Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB
    Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus keratitis in children.
    Chong EM; Wilhelmus KR; Matoba AY; Jones DB; Coats DK; Paysse EA
    Am J Ophthalmol; 2004 Sep; 138(3):474-5. PubMed ID: 15364233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
    Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
    Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of treatment with the Herpes simplex antigen Lupidon H, resp. Lupidon G].
    Schmersahl P; Rüdiger G
    Z Hautkr; 1975 Feb; 50(3):105-12. PubMed ID: 179231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
    Sasaki S; Miyazaki D; Haruki T; Yamamoto Y; Kandori M; Yakura K; Suzuki H; Inoue Y
    Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
    Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
    Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience with the combined treatment of recurrent herpes using larifan and a herpetic vaccine].
    Potekaev NS; Nosik NN; Samgin MA; Kudratullaev KN; Lavrukhina LA
    Klin Med (Mosk); 1992 Jan; 70(1):67-70. PubMed ID: 1318984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Report on Lupidon H and G, a Herpes simplex vaccine (author's transl)].
    Koinis G; Wüthrich B
    Schweiz Rundsch Med Prax; 1975 Sep; 64(37):1176-9. PubMed ID: 1219704
    [No Abstract]   [Full Text] [Related]  

  • 36. Neonatal herpes simplex virus infection: epidemiology and treatment.
    James SH; Kimberlin DW
    Clin Perinatol; 2015 Mar; 42(1):47-59, viii. PubMed ID: 25677996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The therapeutic effect of acyclovir in herpetic keratitis].
    Popa DP; Vasinca D; Ristea L; Mihalachi C; Pop L
    Oftalmologia; 1994; 38(1):73-7. PubMed ID: 8155624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment trials of the therapeutic efficacy of the drug "Zovirax" in some recurrent ocular and genital herpetic infections.
    Muţiu A; Sahnazarov N; Crişan I
    Rom J Virol; 1998; 49(1-4):27-42. PubMed ID: 10892424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex infections: current concepts and therapy.
    Conte ET
    J Am Osteopath Assoc; 1983 Jul; 82(11):861-8. PubMed ID: 6885537
    [No Abstract]   [Full Text] [Related]  

  • 40. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis.
    Wu X; Chen X
    Chin Med J (Engl); 2002 Oct; 115(10):1569-72. PubMed ID: 12490113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.